Podcast - Biopharmaceutical Manufacturing in India: The Challenges - - BioPharm International

ADVERTISEMENT

Podcast - Biopharmaceutical Manufacturing in India: The Challenges




Ajit Mahadevan
Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young

Add this Podcast feed to your media player



Faced with economic pressures and budget constraints, biopharmaceutical companies are increasingly looking at outsourcing as a cost-effective alternative. In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India.

Click here to go to the main podcast page >>>


Related Links:
India Today by Eric Langer
Outsourcing Insights by Jim Miller
Perspectives on Outsourcing
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here